BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15806147)

  • 1. The second loop of occludin is required for suppression of Raf1-induced tumor growth.
    Wang Z; Mandell KJ; Parkos CA; Mrsny RJ; Nusrat A
    Oncogene; 2005 Jun; 24(27):4412-20. PubMed ID: 15806147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin.
    Li D; Mrsny RJ
    J Cell Biol; 2000 Feb; 148(4):791-800. PubMed ID: 10684259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor slug.
    Wang Z; Wade P; Mandell KJ; Akyildiz A; Parkos CA; Mrsny RJ; Nusrat A
    Oncogene; 2007 Feb; 26(8):1222-30. PubMed ID: 16924233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel monoclonal antibody against the second extracellular loop of occludin disrupts epithelial cell polarity.
    Tokunaga Y; Kojima T; Osanai M; Murata M; Chiba H; Tobioka H; Sawada N
    J Histochem Cytochem; 2007 Jul; 55(7):735-44. PubMed ID: 17371936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin.
    Nusrat A; Brown GT; Tom J; Drake A; Bui TT; Quan C; Mrsny RJ
    Mol Biol Cell; 2005 Apr; 16(4):1725-34. PubMed ID: 15659655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line.
    Lan M; Kojima T; Osanai M; Chiba H; Sawada N
    Carcinogenesis; 2004 Dec; 25(12):2385-95. PubMed ID: 15308585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions.
    Rüffer C; Gerke V
    Eur J Cell Biol; 2004 May; 83(4):135-44. PubMed ID: 15260435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes.
    Osanai M; Murata M; Nishikiori N; Chiba H; Kojima T; Sawada N
    Cancer Res; 2006 Sep; 66(18):9125-33. PubMed ID: 16982755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-surface biotinylation to study endocytosis and recycling of occludin.
    Nishimura N; Sasaki T
    Methods Mol Biol; 2008; 440():89-96. PubMed ID: 18369939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11.
    Lui WY; Lee WM; Cheng CY
    Endocrinology; 2001 May; 142(5):1865-77. PubMed ID: 11316752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro.
    Murata M; Kojima T; Yamamoto T; Go M; Takano K; Osanai M; Chiba H; Sawada N
    Exp Cell Res; 2005 Oct; 310(1):140-51. PubMed ID: 16112666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms.
    Zhu L; Li X; Zeng R; Gorodeski GI
    Endocrinology; 2006 Feb; 147(2):977-89. PubMed ID: 16239297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide.
    Everett RS; Vanhook MK; Barozzi N; Toth I; Johnson LG
    Mol Pharmacol; 2006 Feb; 69(2):492-500. PubMed ID: 16288084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phosphorylation hotspot within the occludin C-terminal domain.
    Dörfel MJ; Huber O
    Ann N Y Acad Sci; 2012 Jun; 1257():38-44. PubMed ID: 22671587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom.
    Langbein L; Grund C; Kuhn C; Praetzel S; Kartenbeck J; Brandner JM; Moll I; Franke WW
    Eur J Cell Biol; 2002 Aug; 81(8):419-35. PubMed ID: 12234014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells.
    Bouvry D; Planès C; Malbert-Colas L; Escabasse V; Clerici C
    Am J Respir Cell Mol Biol; 2006 Nov; 35(5):519-27. PubMed ID: 16741163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox Regulation of Cell Contacts by Tricellulin and Occludin: Redox-Sensitive Cysteine Sites in Tricellulin Regulate Both Tri- and Bicellular Junctions in Tissue Barriers as Shown in Hypoxia and Ischemia.
    Cording J; Günther R; Vigolo E; Tscheik C; Winkler L; Schlattner I; Lorenz D; Haseloff RF; Schmidt-Ott KM; Wolburg H; Blasig IE
    Antioxid Redox Signal; 2015 Nov; 23(13):1035-49. PubMed ID: 25919114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP perturbs inter-Sertoli tight junction permeability barrier in vitro via its effect on proteasome-sensitive ubiquitination of occludin.
    Lui WY; Lee WM
    J Cell Physiol; 2005 Jun; 203(3):564-72. PubMed ID: 15605377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight junctions and cell-cell interactions.
    Utech M; Brüwer M; Nusrat A
    Methods Mol Biol; 2006; 341():185-95. PubMed ID: 16799199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.